EGFR and non-small cell lung carcinoma: Previous studies have developed prognostic models including sex, age, operative approach, examined lymph nodes, vascular invasion, and EGFR gene mutation for stage IA NSCLC but ignored GGO components and LUAD subtypes (Merritt et al., 2020; Yang et al., 2020; Cai et al., 2021).